The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
i've mad the mistake twice over the past month of selling too soon and missed out on a c.100% rise and a 60% rise on the two occasions by a matter of days on both, the compounded gain even bigger.
plan is not to make the same mistake here, just need patience, we know what's coming, we can see where this should be when comparing to where others in the same peer group are, it's just a matter of time
haha, Mavern*
excellent work marve
Doris Ann and co are prob in direct discussions with David Budd now, no need for public posts
FDA and WHO approvals may have been submitted contemporaneous to CE Mark, we know from the RNS that the CE Mark application was done in a manner that would support FDA and WHO approvals thus there may also be some time saving there
Some here are timewasters, let them do their own research, best not to give them oxygen. Ive yet to hear them produce an original bit of research or to challenge a negative view. All I see from them is critique other's research or positive opinions.
BTW that £7.90 is based on one year sales and without any of the ther assets of GDR, just the SARs Cov 2 alone
Agree Ghia, and per my earlier post, GDR value at production capacity is £7.90 a share!
#GDR already has distrib. networks in S.Asia, Asia Pacific, Europe and Gov contracts w/the US. Current testing market demand far outstrips below prod figures. (As seen from #NCYT). At just below figures, pricing GDR on 1 year P/E alone is mcap of £7.90 p/share!
#GDR Prod capacity 10K tests p/hour; w/2 hour daily break, that's 220K tests a day, 1.5M a week and 6.1M a month.
£8 a test (low side) is £49.3M a month gross revenue and £29.6M at 60% margin MONTHLY for a £90M MCAP. Re-rate!
This is current levels, BEFORE any prod increases!
NB. Hours per day of production are an assumption based on what ODX advertised for - 24/7 production. Other figures are from 5th May Rns (if memory serves me correctly)
theres been posts on twitter today showing job adverts for 24 hour production, for Omega Diagnostics. Got me thinking, if they're running 24 hour prod cycles, whats to say GDR wouldnt?
Aside from any potential supply constraints, and say a 2 hour daily downtime for machinery, breaks etc, at 10K tests per hour that's 220K tests a day, 1.5M a week and 6.1M a month. £8 a test (low side) makes it £49.3M a month gross revenue and £29.6M at 60% margin monthly!
And, we also know that scope exists that production level can be scaled up further
great work marve and strongboes on the media emails
THis should be trading at about £5-6 already
you're new to AIM, #1 rule, DYOR, dont invest off the back of what you read on BBs, Twitter etc until you've verified yourself. the only shortcut is the shortcut to losing money
RE hindsight investment - exactly, stay away from that thinking, its only useful to evaluate what decisions were made and why to determine whether it was the correct decision based on the circumstances, if not we learn, if it was then we accept it but beyond that dwelling on the shoulda, woulda, couldas will bring nothing but anxiety
just need to be patient guys, ODX stagnated for ages and many were becoming increasingly frustrated and disillusioned, right upto this morning then out of nowhere boom and they're 60% up.
Same will happen here, just need to wait, we are extremely well positioned
anybody got a clip they can post online somehwere?
Just been looking through some of the old RNSs, seems this hit c.£6GBP a share (54MCAP at that time) in 2013 just when they were securing funding to develop their HCV test with Odey AM buying in around those levels in those days.
Fastforward to today and we are at the same sort of mcap but that HCV test is fully developed WHO authorised and ready to be sold into the market in addition to the Covid Test, meaning 1/the HCV test revenues arent fully factored in here and 2/the Covid business is valued at c.£30M.
Gift at these prices, just extreme short term volatility due to IIs repositioning their books because of the influx of placing shares. Once those are cleared and a re-valuation happens, big gains to be had
Some on here feel the need to call out legitimate positivity in a bid to be seen as someone that is tempering sentiment but don't display the same Samaratinism towards highly negative, de-ramping comments....I do wonder why!
the big selling is good, i'd rather get it all out of the way now than they be selling into news, otherwise you get the type of situation you had on Friday
just re-read my message, terrible grammar and bunch of typos, sorry!
anyway, really positive about this, i think we just need to get thru the next two days, once this place malarky is done we will have clearer skies, more news (which has prob been held back a bit because of the placing and the CE) should start to flow and with it likely more attention from the wider investment community. I got in a little high on Friday but these are brillian levels and i trust anyone getting in will do great. Unless your flipping 80 p placing shares these are not the levels to be selling at given the newsflow on the horizon. Heck, even if i had placing shares i'd keep those aswell!